Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis Article

sustainable development goals

publication date

  • February 1, 2017

webpage

published in

start page

  • 127

end page

  • 132

volume

  • 16

issue

  • 2